Pharmacogenetics and personalized medicine: The future for drug prescribing

Zahi Mitri, Maria O. Esmerian, Joseph A. Simaan, Ramzi Sabra, Nathalie Khoueiry Zgheib

Research output: Contribution to journalReview article

7 Citations (Scopus)

Abstract

Pharmacogenetics, the study of interindividual variations in DNA sequence related to drug response, aims at the optimization of treatment regimens based on each patient's unique genetic makeup. Currently, there is a trend towards moving away from the concept of "one drug fits all" to a rather more individualized and personalized medicine. The goal is to define the appropriate drug dose that maximizes efficacy and minimizes toxicity in each individual patient. An example of genotyping for CYP2C9 genetic polymorphisms in patients receiving oral anticoagulants is provided. In spite of its inherent challenges, we hope that pharmacogenetic research and clinical applications expand to improve healthcare outcomes in Lebanon and worldwide.

Original languageEnglish (US)
Pages (from-to)101-104
Number of pages4
JournalJournal Medical Libanais
Volume58
Issue number2
StatePublished - Apr 2010
Externally publishedYes

Fingerprint

Drug Prescriptions
Precision Medicine
Pharmacogenetics
Pharmaceutical Preparations
Lebanon
Genetic Polymorphisms
Anticoagulants
Delivery of Health Care
Research
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Mitri, Z., Esmerian, M. O., Simaan, J. A., Sabra, R., & Zgheib, N. K. (2010). Pharmacogenetics and personalized medicine: The future for drug prescribing. Journal Medical Libanais, 58(2), 101-104.

Pharmacogenetics and personalized medicine : The future for drug prescribing. / Mitri, Zahi; Esmerian, Maria O.; Simaan, Joseph A.; Sabra, Ramzi; Zgheib, Nathalie Khoueiry.

In: Journal Medical Libanais, Vol. 58, No. 2, 04.2010, p. 101-104.

Research output: Contribution to journalReview article

Mitri, Z, Esmerian, MO, Simaan, JA, Sabra, R & Zgheib, NK 2010, 'Pharmacogenetics and personalized medicine: The future for drug prescribing', Journal Medical Libanais, vol. 58, no. 2, pp. 101-104.
Mitri Z, Esmerian MO, Simaan JA, Sabra R, Zgheib NK. Pharmacogenetics and personalized medicine: The future for drug prescribing. Journal Medical Libanais. 2010 Apr;58(2):101-104.
Mitri, Zahi ; Esmerian, Maria O. ; Simaan, Joseph A. ; Sabra, Ramzi ; Zgheib, Nathalie Khoueiry. / Pharmacogenetics and personalized medicine : The future for drug prescribing. In: Journal Medical Libanais. 2010 ; Vol. 58, No. 2. pp. 101-104.
@article{c636bc27169a44e59d14af6082c1da4c,
title = "Pharmacogenetics and personalized medicine: The future for drug prescribing",
abstract = "Pharmacogenetics, the study of interindividual variations in DNA sequence related to drug response, aims at the optimization of treatment regimens based on each patient's unique genetic makeup. Currently, there is a trend towards moving away from the concept of {"}one drug fits all{"} to a rather more individualized and personalized medicine. The goal is to define the appropriate drug dose that maximizes efficacy and minimizes toxicity in each individual patient. An example of genotyping for CYP2C9 genetic polymorphisms in patients receiving oral anticoagulants is provided. In spite of its inherent challenges, we hope that pharmacogenetic research and clinical applications expand to improve healthcare outcomes in Lebanon and worldwide.",
author = "Zahi Mitri and Esmerian, {Maria O.} and Simaan, {Joseph A.} and Ramzi Sabra and Zgheib, {Nathalie Khoueiry}",
year = "2010",
month = "4",
language = "English (US)",
volume = "58",
pages = "101--104",
journal = "Journal Medical Libanais",
issn = "0023-9852",
publisher = "Lebanese Order of Physicians",
number = "2",

}

TY - JOUR

T1 - Pharmacogenetics and personalized medicine

T2 - The future for drug prescribing

AU - Mitri, Zahi

AU - Esmerian, Maria O.

AU - Simaan, Joseph A.

AU - Sabra, Ramzi

AU - Zgheib, Nathalie Khoueiry

PY - 2010/4

Y1 - 2010/4

N2 - Pharmacogenetics, the study of interindividual variations in DNA sequence related to drug response, aims at the optimization of treatment regimens based on each patient's unique genetic makeup. Currently, there is a trend towards moving away from the concept of "one drug fits all" to a rather more individualized and personalized medicine. The goal is to define the appropriate drug dose that maximizes efficacy and minimizes toxicity in each individual patient. An example of genotyping for CYP2C9 genetic polymorphisms in patients receiving oral anticoagulants is provided. In spite of its inherent challenges, we hope that pharmacogenetic research and clinical applications expand to improve healthcare outcomes in Lebanon and worldwide.

AB - Pharmacogenetics, the study of interindividual variations in DNA sequence related to drug response, aims at the optimization of treatment regimens based on each patient's unique genetic makeup. Currently, there is a trend towards moving away from the concept of "one drug fits all" to a rather more individualized and personalized medicine. The goal is to define the appropriate drug dose that maximizes efficacy and minimizes toxicity in each individual patient. An example of genotyping for CYP2C9 genetic polymorphisms in patients receiving oral anticoagulants is provided. In spite of its inherent challenges, we hope that pharmacogenetic research and clinical applications expand to improve healthcare outcomes in Lebanon and worldwide.

UR - http://www.scopus.com/inward/record.url?scp=77954926600&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77954926600&partnerID=8YFLogxK

M3 - Review article

C2 - 20549897

AN - SCOPUS:77954926600

VL - 58

SP - 101

EP - 104

JO - Journal Medical Libanais

JF - Journal Medical Libanais

SN - 0023-9852

IS - 2

ER -